chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Became unconscious, pulse detected when gaining consciousness was really hot and vaccinated arm was tingling. gave water-EMT arrived
This patient had a temperature, after given Tylenol temp was 104.3. She was Hyporesponsive, inconsolably crying, and vomiting, it started at midnight on 01/13/01. The temperature stated before was in the ER at 2PM on 01/13/01. The mother reports the temperature was higher at home. Treatment included 2 baths, Tylenol at home with no response and a mineral bath in the ER.
feeling dizziness and faint  apx 5 min post vaccination.  no s/s of airway obstruction, breathing patent, lung sound clear. skin at injection site appears clear, no redness, no s/s of allergic reaction.  v/s at 1339: 112/84, 74/m, 18/m, 98%. At 1349: 112/82, 68/m, 18/m, 99%.  Patient stated that she drove one hour for vaccine clinic and had taken food 2 hr earlier and had not drank anything since then. she normally reacts to vaccines.
Allergic reaction, red skin, hives, severe itchiness starting at mainly scalp area, face and neck.  Difficulty breathing.  Given IM injection of benedryl
Within 20 minutes of injection she developed a skin rash, bumps, itching in trunk and face, lip swelling with mild shortness of breath. Used all latex-free products. To ED for tx, ATARAX and ZANTAC given.
This case was reported by a consumer via sales rep and described the occurrence of muscle pain in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced muscle pain, fatigue, fever, chills and headache. On an unknown date, the outcome of the muscle pain, fatigue, fever, chills and headache were unknown. It was unknown if the reporter considered the muscle pain, fatigue, fever, chills and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced events (severity: severe) within 8 hours after receiving the shot.
Flu shot was administered at school and within the hour a huge red hard feverish bulge in the upper arm formed.
Respiratory congestion;  stuffy, runny nose; cough (coughed up a lot of mucus), congested lungs, muscle & joint aches; no energy. This started the day after the vaccine, had all the above symptoms for 7 days. Today is day 21, I still have a cough (coughing up mucous), sinuses still not completely clear (still have occasional runny nose) - those are getting better. The sore nut& joints are still an issue.
Extreme muscle aches in pains, extreme back pain to this day, trouble walking, trouble with speech,
suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles 6 times. The patient stated that, if you never had Shingles vaccine, you would get them after been vaccinated. He/she suggested to not took this vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
exposure to skin; invalid dose; exposure to skin; A spontaneous report was received from a healthcare facility staff member concerning male patient who had invalid dose of administration and exposure to skin of Moderna's COVID-19 vaccine.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 18-FEB-2021, the patient received their first of two planned doses of mRNA-1273 (Batch number unknown) intramuscularly for prophylaxis of COVID-19 infection.  The reporter reported that, the syringe cracked, and the Moderna Covid-19 Vaccine ran down patient's arm. Reporter was not sure about the patient received very much of the dose. Treatment information was not provided.  Action taken with second dose of mRNA-1273 in response to the events was not provided.  The outcome of the events, were considered as recovered.; Reporter's Comments: This report refers to a case of vaccine underdose, syringe connection issue and exposure via skin for mRNA-1273 (Batch number unknown) with no associated AEs.
p/vax pt exp flu-like sx & fatigue;no tx was given;pt condition is not yet resolved;
Patient experienced light fainting, lower blood pressure after getting her vaccine. Patient's vitals were normal, patient was observed for 30 min by EMS. Patient felt fine after 30 min. Patient didn't need any treatment.
This spontaneous report as received from a Registered Nurse refers to a 6 month old female patient. On 08-MAY-2013 the patient was vaccinated with an expired dose of ROTATEQ (lot# 0184AA, expiration date 05-OCT-2012) which was the 3rd dose in the series. Additional information has been requested.
Administered Hep A vaccine (VAQTA) on 7/8/16. About 24 hours later patient developed rash. Rash resolving when seen in office on 7/12/16. Recommended BENADRYL/ZYRTEC; Rash non-pruritic.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown ages and genders. On an unkonwn date, the patients were vaccinated with ROTATEQ (dose, route and lot number were not reported), vaccine had been exposed to multiple excursions with highest temperature reaching 57F for total time of 206 hours and these vaccines' stability could not be supported. No adverse effects reported. This is one of several reports from the same source. Follow up information was received with patient identifiers. ROTATEQ was administered a 5 month old patient. ROTATEQ lot number J008725. This is case 3 of 4 patients. This case was linked to cases: 1403USA007267, 1404USA014641, 1404USA014643. Additinoal information has been requested, all scheduled correspondence was scheudled.
Patient received Moderna Covid-19 vaccine at age 16; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received Moderna Covid-19 vaccine at age 16) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received Moderna Covid-19 vaccine at age 16). On 23-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received Moderna Covid-19 vaccine at age 16) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.
Headache x 2 days.  Treated with Nsaids. Did not seek/need medical attention.
Develop a rash on left thigh day after vaccines - 8/26. Rash worse on 8/27. Was prickly & raised little white then red - low grade fever x 1 day. Cranky on 8/26 leg was swollen also that day. Seen 8/30.
moderate diarrhea up to 72 hours; modarate to severe rash on my forearms and top of my both hands; muscle/joint pains; chills; headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (moderate diarrhea up to 72 hours), RASH (modarate to severe rash on my forearms and top of my both hands), ARTHRALGIA (muscle/joint pains), CHILLS (chills) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pruritus (in the late 80s.) in 1980, Rash and Protein S (Protein S/Factor Leiden defficiency). Concurrent medical conditions included Allergy NOS (Allergy to the Sun or mys sweat while outside. Mainly forearms and top of my hands.), Drug allergy (IV Benadryl), Penicillin allergy (She had Allergy to penicillin prescribed for tooth ache in 01/2014 prior to root canal tx.), Drug allergy (She had Allergy to hydrocodone   prescribed for tooth ache in 01/2014 prior to root canal tx.), Thyroid disorder, Blood pressure high (HBP) and Diabetic (May be pre-diabetic). Concomitant products included VALSARTAN for Blood pressure high, METOPROLOL and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (moderate diarrhea up to 72 hours), RASH (modarate to severe rash on my forearms and top of my both hands), ARTHRALGIA (muscle/joint pains), CHILLS (chills), HEADACHE (headache) and PYREXIA (Fever). At the time of the report, DIARRHOEA (moderate diarrhea up to 72 hours), RASH (modarate to severe rash on my forearms and top of my both hands), ARTHRALGIA (muscle/joint pains), CHILLS (chills), HEADACHE (headache) and PYREXIA (Fever) outcome was unknown.            The treatment information was unknown. Action taken with mRNA-1273 in response to the events were not Applicable. Patient stated that Exactly two weeks after her 2nd vaccine his son got sick with Covid. They both  shared the same house. She was isolated and  was careful . she never got sick or experienced any symptos of Covid at that time. She was still recovering from the hysterectomy and had to wait for the root canal since she was on Lovenox tx following her recent surgery She experienced SEVERE hives on her hands and forearms.
Patient given 1 dose each of FLUVIRIN and PNEUMOVAX 23. Patient developed immediate anaphylaxis reaction. Treated with EPIPEN and promptly recovered.
Client had pain at vaccine sites - right and left arms. Tdap & Varicella given in left arm. Client also reported flu like symptoms and was very tired after vaccinations were given on the same day (8/19/2014). Pain in right arm resolved in 4 days. Pain in left arm has worsened since. 08/25/2014 Client noticed red patches on left arm near injection site. Client reports warmth on left arm.
Myalgia upper extremities / muscle pain in arm; Pain in joint involving shoulder region; This case was reported by a pharmacist via call center representative and described the occurrence of myalgia in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2021) for prophylaxis.   On 2nd October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced myalgia and joint pain. On an unknown date, the outcome of the myalgia and joint pain were not recovered/not resolved.   It was unknown if the reporter considered the myalgia and joint pain to be related to Shingrix.  Additional case details were reported as follows: The patient received a dose of Shingrix in left arm. The patient had muscle and joint pain in the both the shoulders and arms. Additional information was not provided.  The reporter consented to follow up. This case has been linked with case US2019215234, reported by same reporter.
Headache; Muscle aches; Weakness; Fatigue; Axillary adenopathy; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Sep2021 at 12:00 as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN); all medications from an unknown date for unknown indication and unknown if ongoing. On 16Aug2021, the patient underwent PCR test via nasal swab for COVID-19 and the result was found to be negative. On 28Sep2021 at 03:00, the patient experienced headache, muscle aches, weakness, fatigue and axillary adenopathy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19 (as reported).  The clinical outcome of the events headache, muscle aches, weakness, fatigue and axillary adenopathy was resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Since 11 December he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affected his palms and soles, and resolve without post-inflammatory changes. Symptoms led him to present to the ER on 12 December where he was treated with oral corticosteroids without clear benefit. He reports having some intermittent laryngeal swelling which he localizes to the base of his neck and causes him to have difficulty taking a breath and inspiratory wheezing; he reports using Albuterol with benefit 3-4 times per week. Symptoms occur at rest; he denies nocturnal and exercise symptoms. No activity limitations. He denies cough and chest tightness. He denies dysphagia, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, known infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 3 December, 8 days prior to onset of symptoms. He has used oral antihistamines with benefit. He denies constitutional symptoms. UCT score today is 8 (0, 2, 1, 1, 2, 1, 1, 0). No history of adverse reactions to prior vaccines.
patient reported on 7/5/21 that on Wednesday after her vaccine she experienced rash on stomach, arms, back, legs, headaches, eyes hurting, legs and back hurting, stomach cramping and neck hurting.  she also reported right sided pain over whole body and numbness in her face.  Patient showed me redness on stomach, recommendedBenadryl.  Patient stated she had already been to the doctor (ruled out bells palsy or stroke due to no facial droop).
Patient received Td and Hepatitis B vaccines, as well as the PPD test, on 07/16/07 and on 07/17/07 experienced fever of 102.2 and dizziness.  Patient noted that she always gets dizzy when she gets a fever.  On 07/18/07 patient went to the doctor's office for a follow up visit, felt much better and fever was gone.
approx 5 minutes p/vax pt exp allergic react; sx included lump in throat, anxiety, & feeling warm inside; transferred to emergency center & treated w/Epi & nasal oxygen;
Patient was admitted to the hospital with pneumonia the evening after her received the vaccine in the morning.   He had been struggling with his COPD/ pneumonia since 3/1/21.   He was hospitalized and died 8 days later
This spontaneous report was received from a pharmacist referring to a 65 year old female patient. The patient's concurrent conditions included diabetes. The patient had no drug/reactions allergies. The patient's concomitant medications included metformin and simvastatin (manufacturer unknown). The patient's historical drugs included PREVNAR 13 received on 07-NOV-2016. On 24-OCT-2017 at "about 13:00", the patient was vaccinated with a booster dose of PNEUMOVAX 23 1 shot , in the right arm, lot # N013541 with expiration date 23-JAN-2019, for prophylaxis (route of administration was not reported). On the same date, the patient also was vaccinated with a dose of influenza virus vaccine (unspecified), 1 shot, in the left arm, for prophylaxis (route of administration, lot # and expiration date were not provided). It was reported that later that day, the patient experienced swelling, redness that was hot to the touch, pain "that went about three quarter of the way around her right arm", below the injection site "in the forearm area". Additionally, the patient experienced chills, low grade fever and loss of appetite. No treatment was given for the adverse events. At the time of reporting the outcome of the events was reported as recovering (also reported as " feeling fine"). The causality assessment between peripheral swelling, erythema, feeling hot, and pain in extremity with the suspect therapies was not provided. The reporting pharmacist considered chills, pyrexia, and decreased appetite to be related to influenza virus vaccine (unspecified). It was also reported that the pharmacist gave nine shots of PNEUMOVAX 23 out of the box on the same date, but this patient was the only one with a reaction.
This spontaneous report as received from a nurse via a company representative refers to a 12 year old female patient. On 01-APR-2014 the patient was vaccinated with the first dose of GARDASIL (dose, route and lot# not reported). The patient's medical history, concurrent condition and drug allergies were not provided. On 01-APR-2014, the patient experienced syncope following administration of GARDASIL. During syncope episode, the patient's hands tightened up, clinched her teeth and jerked a little bit; 5 minutes later the patient was fine. No treatment was given. On 01-APR-2014, the patient recovered from syncope, hands tightened up, clinched her teeth and jerked. Causality was not provided. Additional information has been requested.
I started on April 1st after my sister-in-law called me. She tested positive for COVID. I tested positive as well. I was sneezing two days prior to that. I also had congestion in my chest. I was very tired and hurt everywhere. It went through my whole body. My doctor prescribed medication Molnupiravir which I took 8 capsules a day. They also called in a cough medicine as well. The first week was worse and then slowly got better. I did have a temperature off and on for 3-4 days.
Patient tested positive for COVID on 11/06/2021 Required hospitalization for pneumonia , hypoxia (82% on Room air) . Admitted to hospital on 11/06/2021 Fever up to 101.2 Weakness, shortness of breath, cough/congestion, increased swelling to lower extremities  CXR showed pulmonary vascular congestion and right lower lobe infiltrate BNP is elevated 1018  SARSCOV2 PCR is positive 11/06/2021 requiring 2 L of oxygen by nasal cannula (typically uses 1 liter at home)  Lactic Acid 2.6  Patient is still hospitalized at the time of this report
After shot, started feeling a fluttering and high amount of pressure in my chest from my heart.  It has continued for months randomly where I feel the pressure, fluttering, and skipping a beat of my heart.  Additionally, after getting an eye exam, I was told I have glaucoma suddenly.  After years of never having that, they found pressure in my eyes to be abnormally high.
all caught Covid-19; all caught Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", SUSPECTED COVID-19 (medically significant), outcome "recovered" and all described as "all caught Covid-19".  Additional information: It was reported, Recently, despite receiving the three shots, daughter, son-in-law, and the patient all caught Covid-19 from unvaccinated 2 year old granddaughter. Fortunately it was very mild for all and recovered quickly.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200460245 same reporter/drug/event, different patient;US-PFIZER INC-202200460246 same reporter/drug/event, different patient
4 dose was given, but realized afterwards that the vaccine was past its expiration date. Patient did not experience any adverse effects.
chest pain starting at 330am along with pain as I breath in.  No prior heart problems at all.  Made an appointment with the cardiology (Jun 14).
A report was received from a health care professional on 11/19/03 concerning a male vaccinee more than 65 years old who experienced sniffles, cough, fever, and sore throat up to 1 week after receiving Fluvirin on approximately 11/6/03. On an unspecified date, up to one week after vaccination, the vaccinee experienced sniffles, cough, fever, and sore throat. Results of a chest x-ray taken on an unspecified date were negative. The outcome of the event was reported as unknown. There was insufficient information to determine the reporter's causality assessment. Update 3/22/04: Follow up information received from a health care professional indicated that a 66 year old vaccinee received Fluvirin on 11/9/03. on 11/15/03, the patient also experienced a high temperature of 100 degrees, nasal drainage and had a productive cough. The patient recovered from these events on 11/20/03. Follow up pending.
Approximately 5 minutes after receiving dose 2 of Moderna, patient reported vision changes and "blacked out". He was immediately pale and sweaty. He had cold, clammy skin and complained of nausea and dizziness and felt lightheaded. His initial blood pressure was 88/63. I closely monitored patient for 30 minutes as his pressure returned to normal. After 30 minutes, he still felt faint and shaky.  We called 911 to have EMS transport him to the nearest ER to be evaluated.